Ponatinib, Free Base

Hazard statements (CLP)

H302+H312+H332

Code

Statements

H302+H312+H332

Harmful if swallowed, in contact with skin or if inhaled

Hazard statements

Toxic if swallowed May be harmful if inhaled or absorbed through the skin Ingestion may result in hypertension (elevated blood pressure), rash, pancreatitis, gastrointestinal disorders, gastrointestinal hemorrhage, abdominal pain, fatigue, headache, xeroderma (dry skin), constipation, arthralgia (joint pain), nausea, cardiovascular disorders, arterial ischemic event, myocardial infarction or worsening coronary artery disease, cardiac failure, stroke or transient ischemic attack (mini-stroke), peripheral arterial disease, hemorrhage, CNS hemorrhage, effusions including pericardial effusion, pleural effusion, and ascites, atrial fibrillation, venous thromboembolism, blood and lymphatic system disorders, pyrexia (fever), infections, pneumonia, sepsis, febrile neutropenia (development of fever/other signs of infection in association with abnormally low number of a certain type of white blood cells), myelosuppression (suppression of the bone marrow's production of blood cells and platelets), anemia, lymphopenia/leukopenia/neutropenia (reduction of different types of white blood cells), thrombocytopenia (reduced blood platelets), elevated lipase, elevated transaminases Exposure may cause irritation of the skin, eyes, mucous membranes, and upper respiratory tract H302+312+332 - Harmful if swallowed, in contact with skin or if inhaled

Signal word

Danger

Precautionary statements

P2562 - Do not get in eyes, on skin or on clothing WARNING For Laboratory Research Use Only